DEA Archived Press Releases

Press Releases before January 20, 2025
14 Results - Showing 1 to 10
PRESS RELEASE

DEA’s Third Annual National Family Summit on Fentanyl Highlights Progress in Fight to Save Lives

WASHINGTON – The U.S. Drug Enforcement Administration hosted the third annual National Family Summit on Fentanyl on November 14 and 15. For the past three years, DEA has invited families who have lost a loved one to a fentanyl drug poisoning or overdose to gather in the nation’s capital and...
PRESS RELEASE

Sweeping DEA Operation Targets Pharmacy Burglaries and the Illegal Sale of Addictive Prescription Medications

WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

WASHINGTON – The U.S. Drug Enforcement Administration will recognize National Fentanyl Prevention and Awareness Day on Wednesday, August 21 with extended DEA Museum hours from 6 a.m. to 6 p.m. The Faces of Fentanyl exhibit is one of the museum’s featured exhibits, and commemorates the lives lost to fentanyl. More...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
PRESS RELEASE

DEA Holds Second Annual Family Summit on Fentanyl

WASHINGTON – On September 25 and 26, the U.S. Drug Enforcement Administration hosted the second annual DEA Family Summit on Fentanyl for families from across the country who have experienced the profound loss of a child due to a drug poisoning. U.S. Attorney General Merrick B. Garland and DEA Administrator...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
PRESS RELEASE

DEA Recognizes National Fentanyl Awareness Day

WASHINGTON – DEA is proud to join “Song for Charlie” and many of our valued law enforcement, public health, and non-profit partners in recognizing National Fentanyl Awareness Day. Tomorrow represents an important opportunity to remember the victims of fentanyl poisoning and educate people in our communities about the deadly threat...
PRESS RELEASE

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...